Literature DB >> 16212631

Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients.

Kirsten A Armstrong1, Scott B Campbell, Carmel M Hawley, David L Nicol, David W Johnson, Nicole M Isbel.   

Abstract

Obesity is associated with adverse cardiovascular (CV) parameters and may be involved in the pathogenesis of allograft dysfunction in renal transplant recipients (RTR). We sought the spectrum of body mass index (BMI) and the relationships between BMI, CV parameters and allograft function in prevalent RTR. Data were collected at baseline and 2 years on 90 RTR (mean age 51 years, 53% male, median transplant duration 7 years), categorized by BMI (normal, BMI < or = 24.9 kg/m2; pre-obese, BMI 25-29.9 kg/m2; obese, BMI > or = 30 kg/m2). Proteinuria and glomerular filtration rate (eGFR(MDRD)) were determined. Nine percent RTR were obese pre-transplantation compared to 30% at baseline (p < 0.001) and follow-up (25 +/- 2 months). As BMI increased, prevalence of metabolic syndrome and central obesity increased (12 vs 48 vs 85%, p < 0.001 and 3 vs 42 vs 96%, p < 0.001, respectively). Systolic blood pressure, fasting blood glucose and lipid parameters changed significantly with BMI category and over time. Proteinuria progression occurred in 65% obese RTR (23 (13-59 g/mol creatinine) to 59 (25-120 g/mol creatinine)). BMI was independently associated with proteinuria progression (beta 0.01, p = 0.008) but not with changing eGFR(MDRD.) In conclusion, obesity is common in RTR and is associated with worsening CV parameters and proteinuria progression.

Entities:  

Mesh:

Year:  2005        PMID: 16212631     DOI: 10.1111/j.1600-6143.2005.01073.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  19 in total

1.  Association of metabolic syndrome with development of new-onset diabetes after transplantation.

Authors:  Nathaniel D Bayer; Philip T Cochetti; Mysore S Anil Kumar; Valerie Teal; Yonghong Huan; Cataldo Doria; Roy D Bloom; Sylvia E Rosas
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

2.  Biliopancreatic diversion in a renal transplant patient.

Authors:  Maite López Deogracias; Agustin Domínguez-Diez; Rosa Palomar-Fontanet; Monica González-Noriega; E Rodrigo; G Fernández-Fresnedo; J A Zubimendi; Francisco Olmedo; Manuel Gómez-Fleitas; M Arias; Carlos Fernández-Escalante
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

3.  Risk factors for metabolic syndrome in stable Italian renal transplant patients.

Authors:  Fabio Fabbian; Maurizio Bergami; Christian Molino; Alfredo De Giorgi; Marco Pala; Carlo Longhini; Francesco Portaluppi
Journal:  Clin Exp Nephrol       Date:  2011-03-01       Impact factor: 2.801

Review 4.  Primary care of the renal transplant patient.

Authors:  Gaurav Gupta; Mark L Unruh; Thomas D Nolin; Peggy B Hasley
Journal:  J Gen Intern Med       Date:  2010-04-27       Impact factor: 5.128

5.  Effect of kidney transplantation on sleep-disordered breathing in patients with End Stage Renal Disease: a polysomnographic study.

Authors:  Sanjiv Mahajan; Kartik Gupta; Sanjeev Sinha; Atul Malhotra; Sandeep Mahajan
Journal:  Sleep Med       Date:  2018-02-15       Impact factor: 3.492

6.  Effect of pre and post-transplant body mass index on pediatric kidney transplant outcomes.

Authors:  Safaa M Abdelrahman; Basma Samir; Eman Abobakr Abd Alazem; Noha Musa
Journal:  BMC Pediatr       Date:  2022-05-21       Impact factor: 2.567

7.  Metabolic syndrome and coronary artery calcification in renal transplant recipients.

Authors:  Gbemisola A Adeseun; Maria E Rivera; Subhashini Thota; Marshall Joffe; Sylvia E Rosas
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

Review 8.  New-onset diabetes mellitus in the kidney recipient: diagnosis and management strategies.

Authors:  Roy D Bloom; Michael F Crutchlow
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

9.  The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.

Authors:  William G Petchey; Ingrid J Hickman; Emma Duncan; Johannes B Prins; Carmel M Hawley; David W Johnson; Katherine Barraclough; Nicole M Isbel
Journal:  BMC Nephrol       Date:  2009-12-10       Impact factor: 2.388

10.  Evaluation of nutrient intake in early post kidney transplant recipients.

Authors:  Mi Ra Rho; Jeong Hyun Lim; Jung Hwa Park; Seung Seok Han; Yon Su Kim; Young Hee Lee; Won Gyoung Kim
Journal:  Clin Nutr Res       Date:  2013-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.